Ernexa Therapeutics Inc. Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments
Ernexa Therapeutics Inc. (ERNA) had Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments of $216.00 thousand as of 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments · last filed 2016-03-15
- 2015-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $216.00K.
- 2014-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $58.00K.
- 2013-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $83.00K.
- 2012-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $167.00K.
| Period end | Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments |
|---|---|
| 2015-12-31 | $216.00K 10-K · filed 2016-03-15 |
| 2014-12-31 | $58.00K 10-K · filed 2015-03-27 |
| 2013-12-31 | $83.00K 10-K · filed 2014-03-31 |
| 2012-12-31 | $167.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |